quinonemethid
triterpen
celastrol
pristimerin
tingenon
iguesterin
isol
triterygium
regelii
dihydrocelastrol
synthes
hydrogen
palladium
catalyst
isol
quinonemethid
triterpen
evalu
sarscov
pro
inhibitori
activ
show
potent
inhibitori
activ
ic
valu
lm
respect
wherea
correspond
phenol
moieti
observ
low
activ
ic
lm
result
quinonemethid
moieti
are
hydrophob
ere
assist
exhibit
potent
activ
also
quinonemethid
triterpen
proven
competit
kinet
analysi
quinonemethid
triterpen
celastrol
pristimerin
tingenon
iguesterin
isol
triterygium
regelii
dihydrocelastrol
synthes
hydrogen
palladium
catalyst
isol
quinonemethid
triterpen
evalu
sarscov
pro
inhibitori
activ
show
potent
inhibitori
activ
ic
valu
lm
respect
wherea
correspond
phenol
moieti
observ
low
activ
ic
lm
result
quinonemethid
moieti
are
hydrophob
ere
assist
exhibit
potent
activ
also
quinonemethid
triterpen
proven
competit
kinet
analysi
elsevi
ltd
right
reserv
worldwid
outbreak
lifethreaten
diseas
sever
acut
respiratori
syndrom
sar
caus
infect
sarscov
novel
coronaviru
cov
genom
sarscov
contain
major
annot
open
read
frame
includ
predict
encod
known
viral
protein
includ
replicas
polyprotein
spike
protein
polymeras
membran
protein
n
nucleocapsid
protein
e
small
envelop
protein
replicas
polyprotein
ppla
pplb
encod
sarscov
extens
process
yield
function
subunit
success
viral
propag
sarscov
pro
also
call
main
proteas
pro
mediat
proteolyt
process
replicas
polypeptid
function
protein
play
import
role
viral
replic
activ
site
sarscov
pro
catalyt
dyad
sulfur
nucleophil
imidazol
ring
gener
base
therefor
sarscov
pro
consid
attract
target
develop
effect
drug
sar
date
larg
number
inhibitor
pro
studi
includ
diol
isatin
deriv
anilid
thiazolyl
ketonecontain
peptid
compound
moreov
group
report
triterpenoid
betulin
acid
juniperu
formosana
glycyrrhetin
acid
glycyrrhiza
glabra
deriv
could
inhibit
pro
search
novel
sarscov
pro
inhibitor
medicin
plant
found
meoh
extract
bark
tripteryguim
regelii
celastracea
remark
inhibit
sarscov
pro
activ
inhibit
lgml
subsequ
bioactivityguid
fraction
chcl
extract
led
isol
four
quinonemethid
triterpenoid
deriv
identifi
celastrol
pristimererin
tingenon
iguesterin
basi
spectroscop
analys
fig
regelii
woodi
vine
nativ
eastern
southern
china
korea
japan
taiwan
plant
known
thunder
god
vine
histor
use
tradit
chines
medicin
treat
inflammatori
autoimmun
diseas
rheumatoid
arthriti
ra
system
lupu
erythematosu
psoriat
arthriti
behcet
diseas
number
triterpen
diterpen
sesquiterpen
major
compound
isol
bark
regelii
known
varieti
biolog
activ
good
cytotox
numer
cancer
cell
line
efficaci
sever
rodent
model
arthriti
see
front
matter
elsevi
ltd
right
reserv
abbrevi
ic
inhibitor
concentr
lead
activ
loss
k
inhibit
constant
k
michaelismenten
constant
v
max
maximum
veloc
nmr
nuclear
magnet
reson
inflammatori
diseas
howev
sarscov
pro
inhibitori
activ
report
studi
wish
describ
sarscov
pro
inhibitori
activ
four
quinonemethid
triterpen
deriv
semisynthet
dihydrocelastrol
enzymat
activ
sarscov
pro
measur
modif
method
describ
kuo
et
al
biolog
activ
assess
sarscov
pro
confirm
posit
control
curcumin
inhibit
sarscov
pro
ic
valu
lm
found
ic
valu
rang
lm
sarscov
pro
tabl
dosedepend
fig
celasterol
acid
moieti
inhibit
sarscov
order
confirm
whether
quinonemethid
moieti
play
inhibit
sarscov
pro
celastrol
react
dehydrogen
pd
catalyst
give
dihydrocelastrol
quantit
yield
shown
scheme
accord
schwalb
result
celastrol
possess
electrophil
site
within
b
ring
nucleophil
group
cystein
thiol
group
cell
divis
cycl
protein
react
quinonemethid
michael
addit
result
format
adduct
thu
believ
moieti
would
valuabl
enhanc
inhibitori
activ
pro
fact
result
show
quinonemethid
moieti
ic
lm
increas
potenc
sarscov
pro
inhibit
twofold
compar
reduc
analogu
ic
lm
tabl
view
result
presenc
quinonemethid
moieti
appear
play
rel
signific
role
inhibit
character
inhibitori
mechan
isol
quinonemethid
triterpen
sarscov
pro
activ
began
analysi
mode
inhibit
use
lineweaverburk
dixon
plot
shown
repres
figur
kinet
plot
show
compound
competit
inhibit
mode
action
lineweaverburk
plot
versu
result
famili
straight
line
yaxi
intercept
v
max
intens
min
respect
sarscov
pro
inhibitor
fig
isol
inhibitor
manifest
inhibit
mode
action
k
valu
potent
compound
determin
lm
tabl
found
common
xaxi
intercept
line
correspond
dixon
plot
fig
better
investig
interact
inhibitor
enzym
attempt
molecular
dock
simul
bind
sarscov
pro
activ
site
xray
structur
sarscov
pro
complex
substrateanalogu
inhibitor
code
obtain
protein
data
bank
pdb
http
wwwrcsborgpdb
use
model
analysi
comput
dock
analysi
reveal
iguesterin
fit
well
substratebind
pocket
sarscov
pro
shown
figur
hydroxyl
group
form
hydrogen
bond
oxygen
atom
carbonyl
group
cy
oh
thr
locat
domain
residu
wherea
dihydrocelastrol
form
intermolecular
bond
enzym
besid
hydrophob
interact
fig
iguesterin
bind
mode
differ
betulin
acid
savinin
differ
intermolecular
interact
appar
reflect
smaller
ic
valu
iguesterin
compar
refer
compound
inhibit
pro
moreov
calcul
bind
energi
kcalmol
quinonemethid
triterpen
shown
tabl
dock
experi
support
observ
enzymat
assay
reveal
import
role
quinonemethid
moieti
inhibit
sarscov
pro
although
preliminari
molecular
model
studi
final
proof
critic
argument
constitut
posit
sign
possibl
mechan
summari
identifi
quinonemethid
triterpen
deriv
novel
sarscov
pro
inhibitor
newli
identifi
bioactiv
compound
sarscov
pro
inhibitori
activ
lm
rang
includ
celastrol
pristimerin
tingenon
iguesterin
although
isol
quinonemethid
triterpen
previous
known
compound
first
time
shown
possess
sarscov
pro
inhibitori
activ
hope
preliminari
data
may
abl
open
new
avenu
research
target
toward
reduc
threat
sar
global
commun
research
drug
develop
quinonemethid
triterpen
promis
sarscov
pro
inhibitor
ongo
laboratori
result
report
due
cours
